• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Nordics

Water Street backs CCBR-SYNARC

  • Karin Wasteson
  • 09 April 2013
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Water Street Healthcare Partners has invested in Danish clinical services company CCBR-SYNARC.

CCBR-SYNARC, which comprises two businesses that specialise in outsourced clinical services, marks the GP's first investment from its new fund, Water Street Healthcare Partners III.

Water Street closed the fund last year after receiving $750m of investor commitments in less than eight weeks.

CCBR-SYNARC

  • DEAL:

    Expansion

  • VALUE:

    n/d (c$100m est)

  • LOCATION:

    Copenhagen

  • SECTOR:

    Healthcare providers

  • FOUNDED:

    1998

  • STAFF:

    >500

The firm is currently seeking new opportunities to partner with corporations interested in divesting non-core healthcare businesses and mid-market companies wanting to accelerate growth.

Water Street was introduced to founder Claus Christiansen several years ago to share ideas. The parties kept in touch until 2012, at which point the deal was secured.

Negotiations were completed within less than six months. CCBR was on the lookout for a backer with pharmaceutical expertise, and also valued Water Street's business development strategy.

Water Street will look to grow the business both organically and through strategic acquisitions. With the $100m committed to CCBR-SYNARC, Water Street is planning to invest in further acquisitions - the GP is understood to have a list of potential companies displaying a good fit with CCBR.

Water Street targets investments ranging from $50–500m in four healthcare sectors: distribution, medical products, healthcare services and pharmaceutical products and services.

CCBR-SYNARC is Water Street's second investment in a European-based business. The firm now has 12 portfolio companies specialising in healthcare products and services.

Company
CCBR-SYNARC is a provider of clinical services to pharmaceutical and biotechnology companies.

Headquartered in Copenhagen, Denmark, the company's CCBR business recruits patients worldwide and conducts and manages clinical trials in its dedicated clinical centres.

Its SYNARC business, based in Newark, California, specialises in imaging services, consultation and analysis to track progress throughout a trial's lifecycle. Together, the businesses employ more than 500 doctors, nurses and technicians who are located in 29 research centers across Asia, Europe and the Americas.

People
Claus Christiansen is the founder and chairman of CCBR-SYNARC. Al Heller and Peter Strothman are partners at Water Street.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Nordics
  • Expansion
  • Healthcare
  • Now researching
  • Denmark

More on Nordics

EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
Reima Linnanvirta of Trind VC
Trind VC plans up to five early-stage investments in next six months

VC has deployed around 10% of its second, EUR 55m fund and plans to invest in up to 40 startups

  • Venture
  • 31 August 2023
Mergermarket
Letter from the editor: Unquote is moving to Mergermarket

Unquote Editor Harriet Matthews outlines Unquote.com's upcoming move to the Mergermarket platform and the new capabilities and intelligence that this brings to Unquote readers

  • Industry
  • 30 August 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013